Korea pushes R&D of infectious disease therapeutics and vaccines

The International Vaccine Institute (IVI) and the Institut Pasteur Korea (IPK) have signed a memorandum of understanding...

April 12, 2021 | Monday | News
Hyundai Bioscience repurposes Niclosamide for treating intractable diseases

A research paper by a South Korean biotech company Hyundai Bioscience that demonstrated the drug repurposing of Nic...

April 9, 2021 | Friday | News
Personalized Cancer Treatment – the New Way of Treating the Patient of Tomorrow

There are predictions that the number of cancer cases in Asia will keep rising, as people in this region become wealthie...

April 8, 2021 | Thursday | Opinion
Australia conducts world-first precision-based medicine therapy for brain lymphoma

An Australian research team conducted the world-first precision-based medicine therapy to cure brain lymphoma at th...

April 8, 2021 | Thursday | News
International researchers identifies a globally accessible treatment strategy for COVID-19

An international research collaboration involving researchers from the National University Cancer Institute, Singapore (...

April 1, 2021 | Thursday | News
AbCellera, Gilead Sciences to expedite multi-target antibody discovery programs

British Columbia-based biotechnology firm, AbCellera announced agreements to expand its collaboration with Gilead S...

April 6, 2021 | Tuesday | News
Singapore creates Magnesium-based bioresorbable implant technology for surgeries

SRS Life Sciences, a global company headquartered in Singapore focused on lessening disease burden across emerging natio...

April 8, 2021 | Thursday | News
Daiichi Sankyo starts Ph 1 Trial for Nafamostat Inhalation Formulation to treat COVID-19

Daiichi Sankyo, based in Japan, has announced that it has initiated in Japan a first-in-human phase 1 trial for nafamost...

April 5, 2021 | Monday | News
Korea invents soft brain implant for treating neuro diseases

Researchers have invented a smartphone-controlled soft-brain implant that can be recharged wirelessly from outside the b...

April 1, 2021 | Thursday | News
Australia's Starpharma's launches COVID-19 antiviral nasal spray VIRALEZE in the UK

Melbourne-based biotech Starpharma has launched its antiviral nasal spray VIRALEZE™ into the UK via a large nation...

April 1, 2021 | Thursday | News
Gracell Bio leverages Lonza's expertise in CAR-T cell therapy manufacturing

China based Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to discovering and...

April 1, 2021 | Thursday | News
Singapore creates 3D models to fine-tune radiation dose for nasopharyngeal cancer

Singapore, A*STAR’s Institute of Bioengineering and Nanotechnology (IBN) has teamed up with Singapore Institute of...

March 31, 2021 | Wednesday | News
Bright Peak Therapeutics and Ajinomoto to create novel immunocytokines

Bright Peak Therapeutics Inc., a biotechnology company developing next-generation immunotherapies for cancer and autoimm...

March 26, 2021 | Friday | News
POSTECH produces artificial lung model using 3D printing

Scientists at the Pohang University of Science and Technology (POSTECH) in South Korea have succeeded in producing ...

March 25, 2021 | Thursday | News
Singapore SMART researchers develop rapid immune-profiling assay

Researchers from Critical Analytics for Manufacturing Personalized-Medicine (CAMP), an Interdisciplinary Research...

March 25, 2021 | Thursday | News
Singapore study reveals variation in SARS-CoV-2 neutralizing antibody longevity

Scientists from Duke-NUS Medical School, the National Centre for Infectious Diseases (NCID) and the Agency for Science, ...

March 24, 2021 | Wednesday | News
Singapore develops AI platform to assess blood vessel anomalies

An international team of scientists from Nanyang Technological University, Singapore (NTU Singapore), Brown Un...

March 24, 2021 | Wednesday | News
Australia invests $2.6 M in life-improving research for brain cancer survivors

The Australian government is providing $2.6 million to researchers at the University of Melbourne to use the latest info...

March 23, 2021 | Tuesday | News